Cargando…
Nano and Microemulsions for the Treatment of Depressive and Anxiety Disorders: An Efficient Approach to Improve Solubility, Brain Bioavailability and Therapeutic Efficacy
Most drugs used for the treatment of depression, anxiety and related disorders have low absorption, high metabolism, low brain targeting and/or low water solubility, which can make it hard to formulate them at high strength and can also lead to decreased bioavailability. Incorporating these drugs in...
Autores principales: | Pires, Patrícia C., Paiva-Santos, Ana Cláudia, Veiga, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783281/ https://www.ncbi.nlm.nih.gov/pubmed/36559318 http://dx.doi.org/10.3390/pharmaceutics14122825 |
Ejemplares similares
-
Nanosystems for Brain Targeting of Antipsychotic Drugs: An Update on the Most Promising Nanocarriers for Increased Bioavailability and Therapeutic Efficacy
por: Ferreira, Maria Daniela, et al.
Publicado: (2023) -
Improved oral bioavailability of poorly water-soluble glimepiride by utilizing microemulsion technique
por: Li, Haiying, et al.
Publicado: (2016) -
Liposome-Derived Nanosystems for the Treatment of Behavioral and Neurodegenerative Diseases: The Promise of Niosomes, Transfersomes, and Ethosomes for Increased Brain Drug Bioavailability
por: Pires, Patrícia C., et al.
Publicado: (2023) -
Lipid and Polymeric Nanoparticles: Successful Strategies for Nose-to-Brain Drug Delivery in the Treatment of Depression and Anxiety Disorders
por: Alberto, Margarida, et al.
Publicado: (2022) -
Toxicity Evaluation of Microemulsion (Nano Size) of Sour Cherry Kernel Extract for the Oral Bioavailability Enhancement
por: Salimi, Anayatollah, et al.
Publicado: (2014)